Okeene Dentistry & Braces Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 207 E F St, Okeene, OK 73763 Phone: 580-822-3266 |
News Archive
Millions of middle-aged and older men experience the symptoms of an enlarged prostate multiple times during the day and night. What they may not know is that the disease known as BPH (benign prostatic hyperplasia), marked by urgency and frequent urination, is not one but at least a pair of disorders, and that one of the pair - tied to a newly identified gene - has far more serious implications.
Conatus Pharmaceuticals Inc. and the University of Alberta announced today the treatment of the first patient in an investigator-initiated islet cell transplant Phase I/II trial of emricasan (IDN-6556), a pan-caspase inhibitor.
Bayer HealthCare Pharmaceuticals announced today that an orphan drug designation has been granted by the U.S. Food and Drug Administration for ciprofloxacin dry powder inhaler for management of pulmonary infection due to Pseudomonas aeruginosa in cystic fibrosis patients. A similar designation has already been granted by the European Medicines Agency.
Vikki Hazelwood, PhD, a professor in the Department of Biomedical Engineering, Chemistry and Biological Sciences at Stevens Institute of Technology, has received a $50,000 Innovation Grant from New Jersey Health Foundation/The Nicholson Foundation to advance research into a catheter that may prevent frequent complications for patients following a variety of surgical procedures, announced James M. Golubieski, president of New Jersey Health Foundation.
Warner Chilcott plc today announced that its subsidiaries, Warner Chilcott Company, LLC and Warner Chilcott Finance LLC, plan to issue an aggregate principal amount of $750 million of senior notes due 2018 in a private placement.
› Verified 2 days ago